Details for New Drug Application (NDA): 018557
✉ Email this page to a colleague
The generic ingredient in FANSIDAR is pyrimethamine; sulfadoxine. There are three drug master file entries for this compound. Additional details are available on the pyrimethamine; sulfadoxine profile page.
Summary for 018557
Tradename: | FANSIDAR |
Applicant: | Roche |
Ingredient: | pyrimethamine; sulfadoxine |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;500MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription